tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kyle Rose, 195 are a BUY (82.98%), 39 are a HOLD (16.6%), 1 are a SELL (0.43%).
Analyst Kyle Rose, carries an average stock price target met ratio of 58.87% that have a potential upside of 27.77% achieved within 276 days. Previously, Kyle Rose worked at CANACCORD.
Kyle Rose’s has documented 469 price targets and ratings displayed on 31 stocks. The coverage was on Healthcare, Technology, Consumer Cyclical, Financial Services sectors.
Most recent stock forecast was given on PODD, Insulet at 21-Nov-2025.
Analyst best performing recommendations are on SGMS (SCIENTIFIC GAMES).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 1/11/2021. The price target of $25 was fulfilled within 2 days with a profit of $2.78 (12.51%) receiving and performance score of 62.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2026
$16
$5.88 (58.10%)
$15
1 months 25 days ago
(05-Aug-2026)
0/2 (0%)
$6.43 (67.19%)
Buy Since 19-Oct-2020
$13
$2.88 (28.46%)
$11
1 months 25 days ago
(05-Aug-2026)
6/10 (60%)
$3.43 (35.84%)
255
Buy Since 01-Aug-2024
$12
$1.88 (18.58%)
$11
1 months 25 days ago
(05-Aug-2026)
2/4 (50%)
$2.43 (25.39%)
234
Buy Since 09-Mar-2026
$13
$2.88 (28.46%)
$20
2 months 22 days ago
(08-Jul-2026)
1/4 (25%)
$3.79 (41.15%)
13
Buy Since 05-Aug-2019
$14
$3.88 (38.34%)
$14
4 months 2 days ago
(28-May-2026)
19/23 (82.61%)
$6.11 (77.44%)
542
